Allergy Research Group

Allergy Research Group

Hypoallergenic supplements backed by research

Overview

Allergy Research Group makes hypoallergenic dietary supplements using pure raw materials. They source ingredients and develop formulations designed to minimize allergen exposure, backed by scientific research. The products deliver nutrients or bioactive compounds in hypoallergenic forms and follow strict quality controls to avoid common allergens and contaminants. The company differentiates itself through its long history (since 1979), emphasis on hypoallergenic ingredient profiles, and evidence-based formulation rather than relying on trend-driven products. Its goal is to provide safe, effective nutritional supplements for people with allergies or sensitivities that support health without triggering allergic reactions.

Significant Headcount Growth

About Allergy Research Group

Simplify's Rating
Why Allergy Research Group is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Healthcare

Consumer Goods

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

South Salt Lake, Utah

Founded

1979

Get referred to Allergy Research Group

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • February 2026 peer-reviewed thyroid paper gives sales teams fresh clinical credibility.
  • Metabolic Maintenance integration adds stress and mood products, expanding wallet share in 2025.
  • New products page updated May 5, 2026 signals active pipeline and ongoing catalog refresh.

What critics are saying

  • SupplementChecker lists two recalls and one adverse event, pressuring trust with practitioners.
  • 2004 FDA warning letter shows recurring claims-compliance risk if marketing overstates benefits.
  • WM Partners ownership since 2023 creates exit pressure; underperforming integration can force a sale.

What makes Allergy Research Group unique

  • 45-plus years in hypoallergenic, practitioner-focused supplements differentiates ARG from mass brands.
  • February 4, 2026 endocrine science publication strengthens ARG’s evidence-based positioning.
  • January 2025 Metabolic Maintenance acquisition broadened ARG beyond allergy into mood and metabolic categories.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

↑ 7%

1 year growth

↑ 7%

2 year growth

↑ 7%
FinSMEs
Jul 7th, 2023
WM Partners acquires Allergy Research Group

WM Partners, a certified diverse-owned private equity firm focused on investing in middle market companies and driving value creation in the health and wellness sector, today announced that HPH III Investments, LP, together with its parallel and feeder funds (“HPH III”), through its wholly owned entity, has acquired Allergy Research Group, a subsidiary of KI NutriCare (“KIN”), from Kikkoman Corporation.

PitchBook
Jul 7th, 2023
Global PE deals for July 7, 2023 | PitchBook

WM Partners has acquired Allergy Research Group, a hypoallergenic supplement retailer founded in 1979, from Kikkoman subsidiary KI Nutricare.

PR Newswire
Jul 6th, 2023
WM Partners announces acquisition of Allergy Research Group

WM Partners announces acquisition of Allergy Research Group.

Recently Posted Jobs

Sign up to get curated job recommendations

Allergy Research Group is Hiring for 10 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →